Shengfen Wang

2.5k total citations · 2 hit papers
48 papers, 1.7k citations indexed

About

Shengfen Wang is a scholar working on Epidemiology, Infectious Diseases and Surgery. According to data from OpenAlex, Shengfen Wang has authored 48 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Epidemiology, 41 papers in Infectious Diseases and 15 papers in Surgery. Recurrent topics in Shengfen Wang's work include Tuberculosis Research and Epidemiology (41 papers), Mycobacterium research and diagnosis (40 papers) and Infectious Diseases and Tuberculosis (7 papers). Shengfen Wang is often cited by papers focused on Tuberculosis Research and Epidemiology (41 papers), Mycobacterium research and diagnosis (40 papers) and Infectious Diseases and Tuberculosis (7 papers). Shengfen Wang collaborates with scholars based in China, Netherlands and United States. Shengfen Wang's co-authors include Yanlin Zhao, Bing Zhao, Yuanyuan Song, Hui Xia, Xichao Ou, Guangxue He, Daniel P. Chin, Lixia Wang, Yu Wang and Yang Zhou and has published in prestigious journals such as New England Journal of Medicine, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

Shengfen Wang

43 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

National Survey of Drug-Resistant Tuberculosis in China

2012 491 citations Yanlin Zhao, Lixia Wang et al. profile →
Tuberculosis prevalence in China, 1990–2010; a longitudinal analysis of national survey data

2014 407 citations Lixia Wang, Hui Zhang et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shengfen Wang China	16	1.5k	1.3k	635	228	129	48	1.7k
Yu Pang China	21	997 0.7×	896 0.7×	371 0.6×	134 0.6×	98 0.8×	60	1.2k
Xichao Ou China	15	1.0k 0.7×	919 0.7×	422 0.7×	186 0.8×	80 0.6×	55	1.2k
Guanglu Jiang China	20	1.2k 0.8×	1.0k 0.8×	593 0.9×	181 0.8×	78 0.6×	66	1.4k
Chongguang Yang China	21	1.3k 0.8×	1.1k 0.8×	469 0.7×	346 1.5×	94 0.7×	59	1.5k
Violet Chihota South Africa	23	1.3k 0.9×	1.1k 0.8×	474 0.7×	70 0.3×	41 0.3×	73	1.6k
Moisés Palaci Brazil	30	2.1k 1.4×	1.9k 1.4×	682 1.1×	318 1.4×	136 1.1×	96	2.6k
Jenny Allen South Africa	7	1.8k 1.2×	1.5k 1.1×	931 1.5×	210 0.9×	88 0.7×	7	2.0k
Willy Ssengooba Uganda	21	926 0.6×	738 0.6×	397 0.6×	90 0.4×	33 0.3×	70	1.1k
Nyanda Elias Ntinginya Tanzania	16	754 0.5×	576 0.4×	226 0.4×	157 0.7×	68 0.5×	79	1.1k
Norbert Heinrich Germany	23	1.3k 0.9×	889 0.7×	457 0.7×	179 0.8×	77 0.6×	63	1.6k

Countries citing papers authored by Shengfen Wang

Since Specialization

Citations

This map shows the geographic impact of Shengfen Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengfen Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengfen Wang more than expected).

Fields of papers citing papers by Shengfen Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shengfen Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengfen Wang. The network helps show where Shengfen Wang may publish in the future.

Co-authorship network of co-authors of Shengfen Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Shengfen Wang. A scholar is included among the top collaborators of Shengfen Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengfen Wang. Shengfen Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yang, Wei, Xichao Ou, Bing Zhao, et al.. (2025). High-Level Primary Pretomanid-Resistant with ddn In-Frame Deletion of Mycobacterium tuberculosis and Its Association with Lineage 4.5 in China. ACS Omega. 10(25). 26551–26559. 1 indexed citations

Liu, Dongxin, Bing Zhao, Zheng Yang, et al.. (2024). Characterization of isoniazid resistance and genetic mutations in isoniazid-resistant and rifampicin-susceptible Mycobacterium tuberculosis in China. SHILAP Revista de lepidopterología. 3(3). 100129–100129. 4 indexed citations

Ou, Xichao, Bing Zhao, Qian Sun, et al.. (2024). Development and preliminary assessment of the iFIND TBR: all-in- one molecular diagnostic assay for rapid detection of Mycobacterium tuberculosis and rifampicin resistance. Frontiers in Cellular and Infection Microbiology. 14. 1439099–1439099.

He, Wencong, Yun‐Hong Tan, Binbin Liu, et al.. (2024). Transmission dynamics of tuberculosis in a high-burden area of China: An 8-year population-based study using whole genome sequencing. International Journal of Infectious Diseases. 147. 107210–107210. 1 indexed citations

He, Wencong, Xiaolong Cao, Aijing Ma, et al.. (2024). The Recent Transmission and Associated Risk Factor of Mycobacterium tuberculosis in Golmud City, China. Infection and Drug Resistance. Volume 17. 417–425. 2 indexed citations

Zheng, Huiwen, Yi‐Ting Wang, Wencong He, et al.. (2023). Letter to the Editor: In Vitro Activity of Oxazolidinone Against Nontuberculous Mycobacteria in China. Microbial Drug Resistance. 29(3). 112–114.

Xia, Hui, Yuanyuan Song, Yang Zheng, et al.. (2023). Proficiency testing for drug susceptibility testing of Mycobacterium tuberculosis complex using commercial broth microdilution plate in China in 2021. Journal of Global Antimicrobial Resistance. 36. 230–236. 2 indexed citations

Xia, Hui, Yuanyuan Song, Zheng Yang, et al.. (2022). Detection of Mycobacterium tuberculosis Rifampicin Resistance Conferred by Borderline rpoB Mutations: Xpert MTB/RIF is Superior to Phenotypic Drug Susceptibility Testing. Dove Medical Press (Taylor and Francis Group). 12 indexed citations

Ou, Xichao, Hui Xia, Shengfen Wang, et al.. (2021). National Proficiency Testing of Molecular Diagnostics for Tuberculosis and Drug Resistance Detection — China, 2014–2019. China CDC Weekly. 3(12). 247–251.

10.

Zhou, Yang, Richard Anthony, Shengfen Wang, et al.. (2020). The epidemic of multidrug resistant tuberculosis in China in historical and phylogenetic perspectives. Journal of Infection. 80(4). 444–453. 14 indexed citations

11.

Ou, Xichao, Qiang Li, Dan Su, et al.. (2020). A pilot study: VereMTB detection kit for rapid detection of multidrug-resistant mycobcterium tuberculosis in clinical sputum samples. PLoS ONE. 15(3). e0228312–e0228312. 6 indexed citations

12.

Liu, Dongxin, Wencong He, Mingxia Jiang, et al.. (2019). Development of a loop-mediated isothermal amplification coupled lateral flow dipstick targeting erm(41) for detection of Mycobacterium abscessus and Mycobacterium massiliense. AMB Express. 9(1). 11–11. 13 indexed citations

13.

Zhou, Yang, Susan van den Hof, Shengfen Wang, et al.. (2017). Association between genotype and drug resistance profiles of Mycobacterium tuberculosis strains circulating in China in a national drug resistance survey. PLoS ONE. 12(3). e0174197–e0174197. 25 indexed citations

14.

Ou, Xichao, Shengfen Wang, Haiyan Dong, et al.. (2016). Multicenter evaluation of a real-time loop-mediated isothermal amplification (RealAmp) test for rapid diagnosis of Mycobacterium tuberculosis. Journal of Microbiological Methods. 129. 39–43. 11 indexed citations

15.

Wang, Shengfen, et al.. (2015). Epidemic characteristics of Mycobacterium tuberculosis of Beijing genotype strains and its association with drug resistance——Analysis of the data from national drug resistant tuberculosis baseline survey in 2007. 37(8). 836–842. 2 indexed citations

16.

Pang, Yu, Yang Zhou, Shengfen Wang, et al.. (2015). Prevalence and risk factors of mixed Mycobacterium tuberculosis complex infections in China. Journal of Infection. 71(2). 231–237. 19 indexed citations

17.

Ou, Xichao, Yuanyuan Song, Bing Zhao, et al.. (2014). A multicenter study of Cross-Priming Amplification for tuberculosis diagnosis at peripheral level in China. Tuberculosis. 94(4). 428–433. 23 indexed citations

18.

Ou, Xichao, Hui Xia, Qiang Li, et al.. (2014). A feasibility study of the Xpert MTB/RIF test at the peripheral level laboratory in China. International Journal of Infectious Diseases. 31. 41–46. 20 indexed citations

19.

Wang, Lixia, Hui Zhang, Yunzhou Ruan, et al.. (2014). Tuberculosis prevalence in China, 1990–2010; a longitudinal analysis of national survey data. The Lancet. 383(9934). 2057–2064. 407 indexed citations breakdown →

20.

Ou, Xichao, Qiang Li, Hui Xia, et al.. (2014). Diagnostic Accuracy of the PURE-LAMP Test for Pulmonary Tuberculosis at the County-Level Laboratory in China. PLoS ONE. 9(5). e94544–e94544. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact